Ushbu ish iqtibos qilgan ishlar
161 ta ish
Ish: Engineering CAR T NK and NKT cell therapies to target cancer stem cells and overcome stem like resistance
The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy
Shuguang Zhang, Wen‐Ying Chen, Jihong Zhou +5
Sharh maqola20259 iqtibosABICancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning +7
Maqola20248 iqtibosABILysophosphatidic Acid Signaling and microRNAs: New Roles in Various Cancers
Mahdi Rafiyan, Mohammad Hassan Jafari Najaf Abadi, Seyed Saeed Tamehri Zadeh +3
Sharh maqolaOchiq kirish20227 iqtibosABIProspective identification of tumorigenic breast cancer cells
Muhammad Al‐Hajj, Max S. Wicha, Adalberto Benito‐Hernández +2
Maqola20037 iqtibosABIUse of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu, David Marín, Pinaki P. Banerjee +24
Maqola20207 iqtibosABIFerroptosis in cancer: from molecular mechanisms to therapeutic strategies
Qian Zhou, Yu Meng, Daishi Li +7
Sharh maqola20246 iqtibosABICancer stem cells: landscape, challenges and emerging therapeutic innovations
Haksoo Lee, Byeongsoo Kim, Junhyeong Park +7
Sharh maqola20256 iqtibosABITargeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions
Kaveh Hadiloo, Parsa Mostanadi, Ali Asadzadeh +2
Sharh maqola20256 iqtibosABICAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang +2
Sharh maqolaOchiq kirish20245 iqtibosABICAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Kaveh Hadiloo, Safa Tahmasebi, Abdolreza Esmaeilzadeh
Sharh maqola20235 iqtibosABICancer stem cells: a target for overcoming therapeutic resistance and relapse
Shuo Zhang, Rui Yang, Yujie Ouyang +3
Maqola20245 iqtibosABIDrug resistance and Cancer stem cells
Yuan Li, Zhenning Wang, Jaffer A. Ajani +1
Sharh maqola20215 iqtibosABIThe clinical landscape of CAR NK cells
Lasse Vedel Jørgensen, Emil Birch Christensen, Mike Bogetofte Barnkob +1
Sharh maqola20255 iqtibosABITargeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem, Jorge Mansilla‐Soto, Theodoros Giavridis +6
MaqolaOchiq kirish20174 iqtibosABICAR-T Cell Performance: How to Improve Their Persistence?
Gina López-Cantillo, Claudia Urueña, Bernardo Camacho +1
Sharh maqolaOchiq kirish20224 iqtibosABIMelatonin for gastric cancer treatment: where do we stand?
Mahdi Rafiyan, Elham Tootoonchi, Mahdieh Golpour +6
Sharh maqola20244 iqtibosABICircular RNAs and Cancers
Mohammad Mahdi Heidari, Mohammad Saeid Moeinfar, Mahdi Rafiyan +9
Sharh maqola20254 iqtibosABIEngineering and Design of Chimeric Antigen Receptors
Sònia Guedan, Hugo Calderón, Avery D. Posey +1
Sharh maqola20184 iqtibosABIImproving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion
Sharh maqola20224 iqtibosABIDiagnostic technologies for neuroblastoma
Leena Khelifa, Yubing Hu, Jennifer Tall +11
Sharh maqola20254 iqtibosABIDynamic joint prediction model of severe radiation-induced oral mucositis among nasopharyngeal carcinoma: a prospective longitudinal study
Juejin Li, Hong He, Chang Guan +2
MaqolaOchiq kirish20253 iqtibosABI